肝细胞癌
肝硬化
生物标志物
医学
肝细胞癌
内科学
胃肠病学
癌症
肿瘤科
生物
生物化学
作者
Hashem B. El‐Serag,Fasiha Kanwal,Jing Ning,Hannah Powell,Saira Khaderi,Amit G. Singal,Sumeet K. Asrani,Jorge A. Marrero,Christopher I. Amos,Aaron P. Thrift,Michelle Luster,Abeer Alsarraj,Luis Olivares,Darlene G. Skapura,Jenny Deng,Emad A. Salem,Omar Najjar,Xian Yu,Hao T. Duong,Michael E. Scheurer,Christie M. Ballantyne,Salma Kaochar
出处
期刊:Gut
[BMJ]
日期:2024-02-16
卷期号:73 (6): 1000-1007
被引量:7
标识
DOI:10.1136/gutjnl-2024-332034
摘要
Inflammatory and metabolic biomarkers have been associated with hepatocellular cancer (HCC) risk in phases I and II biomarker studies. We developed and internally validated a robust metabolic biomarker panel predictive of HCC in a longitudinal phase III study.
科研通智能强力驱动
Strongly Powered by AbleSci AI